Wall Street analysts expect Ceridian HCM Holding Inc (NYSE:CDAY) to report earnings of $0.10 per share for the current quarter, Zacks reports. Six analysts have issued estimates for Ceridian HCM’s earnings. The highest EPS estimate is $0.12 and the lowest is $0.08. Ceridian HCM posted earnings of $0.05 per share in the same quarter last year, which would suggest a positive year over year growth rate of 100%. The firm is expected to announce its next quarterly earnings report on Monday, November 4th.

On average, analysts expect that Ceridian HCM will report full-year earnings of $0.50 per share for the current year, with EPS estimates ranging from $0.47 to $0.54. For the next fiscal year, analysts forecast that the company will report earnings of $0.68 per share, with EPS estimates ranging from $0.62 to $0.81. Zacks’ EPS calculations are an average based on a survey of analysts that that provide coverage for Ceridian HCM.

Ceridian HCM (NYSE:CDAY) last announced its quarterly earnings results on Tuesday, July 30th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.05. Ceridian HCM had a net margin of 4.19% and a return on equity of 2.34%. The company had revenue of $196.30 million during the quarter, compared to analyst estimates of $192.29 million. During the same quarter in the previous year, the business earned ($0.44) EPS. The firm’s revenue was up 9.7% on a year-over-year basis.

Several equities analysts have recently issued reports on CDAY shares. Credit Suisse Group boosted their price target on shares of Ceridian HCM from $45.00 to $52.00 and gave the company a “neutral” rating in a report on Wednesday, July 31st. Mizuho set a $65.00 price target on shares of Ceridian HCM and gave the company a “buy” rating in a report on Friday, September 6th. Zacks Investment Research lowered shares of Ceridian HCM from a “hold” rating to a “sell” rating in a report on Tuesday, September 17th. ValuEngine lowered shares of Ceridian HCM from a “buy” rating to a “hold” rating in a report on Wednesday, September 4th. Finally, Barclays set a $50.00 price target on shares of Ceridian HCM and gave the company a “hold” rating in a report on Wednesday, July 31st. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the stock. Ceridian HCM currently has a consensus rating of “Hold” and a consensus target price of $56.08.

In related news, Chairman David D. Ossip sold 500,000 shares of the business’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $49.27, for a total value of $24,635,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Thomas H. Lee Advisors, Llc sold 9,500,000 shares of the business’s stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $49.27, for a total transaction of $468,065,000.00. The disclosure for this sale can be found here. Insiders sold a total of 17,201,162 shares of company stock worth $895,176,581 over the last ninety days. 26.90% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of CDAY. OMERS ADMINISTRATION Corp lifted its position in Ceridian HCM by 1.0% during the 2nd quarter. OMERS ADMINISTRATION Corp now owns 21,100 shares of the company’s stock worth $1,074,000 after buying an additional 200 shares in the last quarter. Deutsche Bank AG lifted its position in Ceridian HCM by 23.8% during the 4th quarter. Deutsche Bank AG now owns 1,425 shares of the company’s stock worth $48,000 after buying an additional 274 shares in the last quarter. Captrust Financial Advisors lifted its position in Ceridian HCM by 7.8% during the 2nd quarter. Captrust Financial Advisors now owns 4,408 shares of the company’s stock worth $221,000 after buying an additional 318 shares in the last quarter. Bessemer Group Inc. lifted its position in Ceridian HCM by 2.2% during the 2nd quarter. Bessemer Group Inc. now owns 20,569 shares of the company’s stock worth $1,032,000 after buying an additional 435 shares in the last quarter. Finally, Aperio Group LLC bought a new stake in Ceridian HCM during the 2nd quarter worth about $25,000. 81.29% of the stock is currently owned by institutional investors and hedge funds.

Shares of CDAY stock traded up $0.10 on Tuesday, hitting $51.89. The stock had a trading volume of 1,426,197 shares, compared to its average volume of 1,105,572. Ceridian HCM has a twelve month low of $31.39 and a twelve month high of $58.95. The firm has a market cap of $7.41 billion, a P/E ratio of -1,037.80 and a beta of 1.53. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.40. The company has a fifty day moving average price of $53.77 and a two-hundred day moving average price of $51.33.

Ceridian HCM Company Profile

Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.

See Also: What are the benefits of buying treasury bonds?

Get a free copy of the Zacks research report on Ceridian HCM (CDAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.